Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2568
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study ; day:6 ; month:4 ; year:2022 ; pages:1-10
Digestive diseases and sciences ; (6.4.2022), 1-10
- Urheber
-
Peyrin-Biroulet, Laurent
Bouguen, Guillaume
Laharie, David
Pellet, Gauthier
Savoye, Guillaume
Gilletta, Cyrielle
Michiels, Christophe
Buisson, Anthony
Fumery, Mathurin
Trochu, Jean-Noël
Cacoub, Patrice
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10620-022-07474-z
- URN
-
urn:nbn:de:101:1-2022062421585149043571
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peyrin-Biroulet, Laurent
- Bouguen, Guillaume
- Laharie, David
- Pellet, Gauthier
- Savoye, Guillaume
- Gilletta, Cyrielle
- Michiels, Christophe
- Buisson, Anthony
- Fumery, Mathurin
- Trochu, Jean-Noël
- Cacoub, Patrice
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial
Zinc protoporphyrin is a reliable marker of functional iron deficiency in patients with inflammatory bowel disease
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland
Use of biomarkers of inflammation in the differentiation of iron deficiency and anaemia-lessons from inflammatory bowel disease
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Multicenter registry of pediatric inflammatory bowel disease from a developing country
Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study
Inflammatory bowel disease
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency
Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions
High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease
Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial
Zinc protoporphyrin is a reliable marker of functional iron deficiency in patients with inflammatory bowel disease
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland
Use of biomarkers of inflammation in the differentiation of iron deficiency and anaemia-lessons from inflammatory bowel disease
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Multicenter registry of pediatric inflammatory bowel disease from a developing country
Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study
Inflammatory bowel disease
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency
Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions
High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease
Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial
Zinc protoporphyrin is a reliable marker of functional iron deficiency in patients with inflammatory bowel disease
Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland
Use of biomarkers of inflammation in the differentiation of iron deficiency and anaemia-lessons from inflammatory bowel disease
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Multicenter registry of pediatric inflammatory bowel disease from a developing country
Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study
Inflammatory bowel disease
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency
Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions